Posted on 26 August 2014
A Birmingham manufacturer and exporter of evacuation chairs for people with mobility difficulties has invested in new production development to support its growing business.
Evac+Chair develops its products for schools, universities, hospitals and clients include Aston Villa FC and the Birmingham Hippodrome, as well as venues abroad.
The business has an on-going research and development programme to enable it to take advantage of new technology to meet growing customer demand for flexible emergency equipment.
To support the R&D programme it has collaborated with Birmingham accountants and business advisory firm Smith Cooper, which has helped it secure a rebate on its work through the R&D tax deduction scheme.
It claimed the money back over two years following the development of its innovative Neo-Natal Intensive Care Transport systems and District Nurse products.
It is using the tax credits to support the development of a range of patient restrain systems Recovery+ and Nightingale.
Established in 1985, Evac+Chair has 73 employees and sells over 50% of its products internationally, predominantly to clients in Japan, Germany and the USA.
Mark Wallace, managing director at Evac+Chair, said: “We invest significantly in the development of groundbreaking new chairs and stretchers to provide clients with products that are both comfortable and simple to use, and the technology and insight that we incorporate into our designs meant many of our latest products qualified for an R&D claim.
“The enhanced tax reduction has provided a significant injection of working capital to help us further boost our product offering and to secure contracts with both new and existing clients in the UK and overseas, and the support and advice from Smith Cooper was fundamental to the business during the claim process.”
Ed Saunders, Tax Advisory Partner at Smith Cooper, said: “We have a long-standing relationship with Evac+Chair and worked closely with its management team to identify the products that had the right elements to allow us to submit a strong R&D tax claim.
“By recovering these costs the business is now focusing on the development of a new range of equipment to aid district nurses and the on-going development into Neo-Natal and Pediatric transport systems and patient restraints. We’ll continue to work closely with Mark and the team to ensure on-going innovative product design is recognised and claimed for.”